{
  "company": {
    "name": "Axiom Therapeutics",
    "website": "https://axiom-therapeutics.com/",
    "record": "https://startuphistory.org/c/axiom-therapeutics.com"
  },
  "status": null,
  "history_since": "2024-09-23T19:57:12.000Z",
  "baseline": {
    "snapshot_id": "5641e1839effd86164c844998933edc51e63917e93287f81bffa1301ebf7d8fd",
    "observed_at": "2024-09-23T19:57:12.000Z",
    "headline": "Unlocking the Future of Drug Discovery",
    "description": null,
    "evidence": "https://web.archive.org/web/20240923195712/https://www.axiom-therapeutics.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 0,
  "last_checked": null,
  "live_status": "js_only",
  "messaging": [
    {
      "quote_observed_at": "2025-07-10T07:34:49.000Z",
      "variants": [
        {
          "headline": "Unlocking the Future of Drug Discovery",
          "subhead": null,
          "observed_at": "2024-09-23T19:57:12.000Z",
          "evidence": "https://web.archive.org/web/20240923195712/https://www.axiom-therapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unlocking the Future of Drug Discovery",
          "subhead": null,
          "observed_at": "2025-01-15T00:49:25.000Z",
          "evidence": "https://web.archive.org/web/20250115004925/https://www.axiom-therapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unlocking the Future of Drug Discovery",
          "subhead": "Axiom Therapeutics is developing the next generation of small molecule therapeutics, powered by our machine learning platform.",
          "observed_at": "2025-07-10T07:34:49.000Z",
          "evidence": "https://web.archive.org/web/20250710073449/https://www.axiom-therapeutics.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Unlocking the Future of Drug Discovery",
      "subhead": "Axiom Therapeutics is developing the next generation of small molecule therapeutics, powered by our machine learning platform.",
      "from": "2024-09-23T19:57:12.000Z",
      "to": "2025-07-10T07:34:49.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20250710073449/https://www.axiom-therapeutics.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-09-23T19:57:12.000Z",
          "to": "2025-07-10T07:34:49.000Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Frontier Medicines",
      "record": "https://startuphistory.org/c/frontiermeds.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use AI and covalent chemistry platforms to design covalent small‑molecule drugs for difficult oncology targets."
    },
    {
      "name": "Vividion Therapeutics",
      "record": "https://startuphistory.org/c/vividion.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both focus on covalent chemistry platforms to discover covalent small‑molecule oncology drugs for hard‑to‑target proteins."
    },
    {
      "name": "PharmCADD",
      "record": "https://startuphistory.org/c/pharmcadd.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both license AI‑driven in‑silico drug design platforms to pharma and biotech for small‑molecule discovery."
    },
    {
      "name": "Numerion Labs (formerly Atomwise)",
      "record": "https://startuphistory.org/c/numerionlabs.ai",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both provide AI platforms and collaborations for small‑molecule drug discovery using deep‑learning‑based design."
    },
    {
      "name": "Atomwise",
      "record": "https://startuphistory.org/c/atomwise.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use AI for structure‑based small‑molecule design and partner with pharma to advance preclinical candidates."
    },
    {
      "name": "Isomorphic Labs",
      "record": "https://startuphistory.org/c/isomorphiclabs.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both run AI‑first platforms to design new small‑molecule therapeutics and pursue partnerships with pharma and biotech."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Axiom Therapeutics” company record, https://startuphistory.org/c/axiom-therapeutics.com"
}